Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of BNC105P as 2nd line chemotherapy for advanced malignant pleural mesothelioma.

Trial Profile

Phase II trial of BNC105P as 2nd line chemotherapy for advanced malignant pleural mesothelioma.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs BNC 105 (Primary)
  • Indications Malignant-mesothelioma
  • Focus Therapeutic Use
  • Acronyms B2P2M2
  • Most Recent Events

    • 17 Apr 2015 According to a Bionomics media release, biomarker data from this trial will be presented as a part of a pooled analysis of this and two other trials at the American Association for Cancer Research (AACR) 106th Annual Meeting.
    • 20 Feb 2014 Status changed from active, no longer recruiting to completed, as per the Australian New Zealand Clinical Trials Registry record.
    • 03 Aug 2011 Status changed from recruiting to active, no longer recruiting.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top